Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by W. Wei Xu
C-Reactive Protein-To-Albumin Ratio Is an Independent Poor Prognosis and Improving NCCN-Ipi Score in Newly Diagnosed Diffuse Large B-Cell Lymphoma: A Clinical Analysis of 414 Cases
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Related publications
Immunohistochemical Double Hit Score Enhances NCCN-IPI and Is Associated With Detrimental Outcomes in Refractory or Relapsing Patients With Diffuse Large B Cell Lymphoma
British Journal of Haematology
Hematology
The Derived Neutrophil to Lymphocyte Ratio Is an Independent Prognostic Factor in Patients With Diffuse Large B-Cell Lymphoma
British Journal of Cancer
Cancer Research
Oncology
Global Hypomethylation Is an Independent Prognostic Factor in Diffuse Large B Cell Lymphoma
American Journal of Hematology
Hematology
Secondary Cutaneous Diffuse Large B-Cell Lymphoma Has a Higher International Prognostic Index Score and Worse Prognosis Than Diffuse Large B-Cell Lymphoma, Leg Type
Acta Dermato-Venereologica
Dermatology
Medicine
Prognostic Impact of Tumor-Associated Macrophages, Lymphocyte-To-Monocyte and Neutrophil-To-Lymphocyte Ratio in Newly Diagnosed Diffuse Large B-Cell Lymphoma Patients
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Hypogammaglobulinemia and Hypocomplementemia as Strong Prognostic Factors in Newly Diagnosed Diffuse Large B Cell Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Correlation of Pretreatment 18f-FDG Uptake With Clinicopathological Factors and Prognosis in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma
Nuclear Medicine Communications
Medicine
Nuclear Medicine
Radiology
Imaging
Red Blood Cell Distribution Width and Platelet Counts Are Independent Prognostic Factors and Improve the Predictive Ability of IPI Score in Diffuse Large B-Cell Lymphoma Patients
BMC Cancer
Cancer Research
Oncology
Genetics
Serum miR-22 as Potential Non-Invasive Predictor of Poor Clinical Outcome in Newly Diagnosed, Uniformly Treated Patients With Diffuse Large B-Cell Lymphoma: An Explorative Pilot Study
Journal of Experimental and Clinical Cancer Research
Cancer Research
Oncology
